Exogene
Exogene is a startup headquartered in London, United Kingdom, founded in 2019. It has won about £2.38m in competitive Innovate UK grants since 2023, according to UK Research and Innovation.
Part of the 311 Institute Global Startups Directory (311institute.com). Last updated .
Innovation grants
Exogene has won about £2.38m in competitive Innovate UK grants since 2023.
- TCRlcLNP - Combining long-circulating Lipid Nanoparticles with cancer-targeting T-Cell Receptors to better deliver immunotherapies in the tumour microenvironment. (£541k, 2024)
- SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment (£489k, 2024)
- ST TCR - Unlocking the discovery of novel shared targets and T-cell receptors for precision cancer therapies (£529k, 2023)
- SpeedTCR - Unlocking the discovery of TCRs for HLA-peptide based and other precision cancer therapies (£352k, 2023)
- RMISTCR - Rapidly mining the immune system for rare therapeutic T-Cell Receptors to treat solid tumour cancers (£466k, 2023)
R&D ecosystem
Exogene sits inside the London and the Golden Triangle R&D ecosystem in the Global R&D Labs Directory.
Other startups in London
- Abtrace
- Adjsoft
- Aeon Energy
- Amphibio
- Anserine Labs
- APIContext
- Apoha
- AppyParking
- Archangel Lightworks
- Arda Biomaterials
- Bark
Related
- Innovation profile of London
- United Kingdom: economy and key statistics
- Global Investors Directory
- All 311 Indexes
Questions and answers
What does Exogene do?
Exogene works in biotechnology. Its Innovate UK projects include: TCRlcLNP - Combining long-circulating Lipid Nanoparticles with cancer-targeting T-Cell Receptors to better deliver immunotherapies in the tumour microenvironment..
Where is Exogene based?
Exogene is headquartered in London, United Kingdom.
When was Exogene founded?
Exogene was founded in 2019.
Source records: Companies House and UK Research and Innovation.
© 311 Institute 2026. Facts from the official sources linked on this page. The selection, classification and links are the proprietary work of the 311 Institute, protected by copyright and database rights.